Two insider buys in the last year — $27.94M in all.
Nothing in the last fortnight.
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
10% owner
GSK plc
Bought $27.93M on Dec 11 — 1,470,000 sh @ $19.00, held indirect, 8.1% of their stake.
10% owner
Ra Capital Management, L.p.
Bought $6.7K on Nov 13 — 1,000 sh @ $6.69, held indirect, 0.0% of their stake.
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
Context
Wall St
+391.9% vs today · 16 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
Coverage
The file stays open
97 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice